MIR34A and carcinoma: Myeloid cell-specific deletion of Mir34a in Apc<sup>Min/+</sup> mice increased tumor initiation and allowed progression towards invasive carcinomas, which are generally not observed in Apc<sup>Min/+</sup> mice.